Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals

Bibliography

• Kinter LB, Siegl PKS, Bass AS. New preclinical guidelines on drug effects on ventricular repolarization: safety pharmacology comes of age. J Pharmacol Toxicol Methods 2004;49(3):153-8
   PubMedGoogle Scholar
• Williams PD. The role of pharmacological profiling in safety assessment. Regul Toxicol Pharmacol 1990;12(3 Pt 1):238-52
   PubMed Web of Science ®Google Scholar
• S7B: the nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use; 2005. p. 61133-4
   Google Scholar
• Sedmera D, McQuinn T. Embryogenesis of heart muscle. Heart Fail Clin 2008;4(3):235-45
   PubMedGoogle Scholar
• Forleo GB, Tondo C. Atrial fibrillation: cure or treat? Ther Adv Cardiovasc Dis 2009;3(3):187-96
   PubMedGoogle Scholar
• Valentin J-P. Reducing QT liability and proarrhythmic risk in drug discovery and development. Br J Pharmacol 2010;159(1):5-11
   PubMed Web of Science ®Google Scholar
• Chan ASY, Isbister GK, Kirkpatrick CMJ, Duffull SB. Assessing risk of a prolonged QT interval-a survey of emergency physicians. Int J Emerg Med 2008;1(1):35-41
   PubMedGoogle Scholar
• Christensen TF, Tarnow L, Randlov J, QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction. Diabetologia 2010;53(9):2036-41
   PubMed Web of Science ®Google Scholar
• Drici MD, Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 2001;24(8):575-85
   PubMed Web of Science ®Google Scholar
• Ponte ML, Keller GA, Di Girolamo G. Mechanisms of drug induced QT interval prolongation. Curr Drug Saf 2010;5(1):44-53
   PubMedGoogle Scholar
• Keating MT, Sanguinetti MC. Molecular and cellular mechanisms review of cardiac arrhythmias. Cell 2001;104:569-80
   PubMed Web of Science ®Google Scholar
• Sanguinetti MC. HERG1 channelopathies. Pflugers Arch 2010;460(2):265-76
   PubMed Web of Science ®Google Scholar
• Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest 2003;112(6):810-15
   PubMed Web of Science ®Google Scholar
• Bains W, Basman A, White C. HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study. Prog Biophys Mol Biol 2004;86(2):205-33
   PubMed Web of Science ®Google Scholar
• Diaz GJ, Daniell K, Leitza ST, The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: comparison of intact cell and membrane preparations and effects of altering [K+]o. J Pharmacol Toxicol Methods 2010;50(3):187-99
   Google Scholar
• Finlayson K, Turnbull L, January CT, [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur J Pharmacol 2001;430(1):147-8
   PubMed Web of Science ®Google Scholar
• Chiu PJS, Marcoe KF, Bounds SE, Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. J Pharmacol Sci 2004;95(3):311-19
   PubMed Web of Science ®Google Scholar
• Daniel S, Malkowitz L, Wang HC, Screening for potassium channel modulators by a high through-put 86-rubidium efflux assay in a 96-well microtiter plate. J Pharmacol Methods 1991;25(3):185-93
   PubMedGoogle Scholar
• Gill S, Gill R, Lee SS, Flux assays in high throughput screening of ion channels in drug discovery. Assay Drug Dev Technol 2003;1(5):709-17
   PubMed Web of Science ®Google Scholar
• Rezazadeh S, Hesketh JC, Fedida D. Rb+ Flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ Efflux assay. J Biomol Screen 2004;9(7):588-97
   PubMed Web of Science ®Google Scholar
• Mitcheson JS, Chen J, Lin M, A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000;97(22):12329-33
   PubMed Web of Science ®Google Scholar
• Kongsamut S, Kang J, Chen X-L, A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs. Eur J Pharmacol 2002;450(1):37-41
   PubMed Web of Science ®Google Scholar
• Castelletti L, Memo M, Missale C, Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs. J Physiol 1989;410:251-65
   PubMed Web of Science ®Google Scholar
• Miller SS, Edelman JL. Active ion transport pathways in the bovine retinal pigment epithelium. J Physiol 1990;424:283-300
   PubMed Web of Science ®Google Scholar
• Dick E, Rajamohan D, Ronksley J, Denning C. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans 2010;38(4):1037-45
   PubMedGoogle Scholar
• Muller M, Fleischmann BK, Selbert S, Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 2000;14(15):2540-8
   PubMed Web of Science ®Google Scholar
• Pekkanen-Mattila M, Chapman H, Kerkela E, Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype. Exp Biol Med (Maywood) 2010;235(4):522-30
   PubMed Web of Science ®Google Scholar
• Sartiani L, Bettiol E, Stillitano F, Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 2007;25(5):1136-44
   PubMed Web of Science ®Google Scholar
• Tanaka T, Tohyama S, Murata M, In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 2009;385(4):497-502
   PubMed Web of Science ®Google Scholar
• Zhu W-Z, Santana LF, Laflamme MA. Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS ONE 2009;4(4):e5407
   PubMedGoogle Scholar
• Zwi L, Caspi O, Arbel G, Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009;120(15):1513-23
   PubMed Web of Science ®Google Scholar
• Guo L, Guthrie H. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation. J Pharmacol Toxicol Methods 2005;52(1):123-35
   PubMedGoogle Scholar
• Kiss L, Bennett PB, Uebele VN, High throughput ion-channel pharmacology: planar-array-based voltage clamp. Assay Drug Dev Technol 2003;1(1 Pt 2):127-35
   PubMed Web of Science ®Google Scholar
• Kutchinsky J, Friis S, Asmild M, Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance. Assay Drug Dev Technol 2003;1(5):685-93
   PubMed Web of Science ®Google Scholar
• Robertson GA, Warmke JM, Ganetzky B. Potassium currents expressed from Drosophila and mouse eag cDNAs in Xenopus oocytes. Neuropharmacology 1996;35(7):841-50
   PubMed Web of Science ®Google Scholar
• Witchel HJ, Milnes JT, Mitcheson JS, Hancox JC. Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. J Pharmacol Toxicol Methods 2002;48(2):65-80
   PubMed Web of Science ®Google Scholar
• Baldi L, Muller N, Picasso S, Transient gene expression in suspension HEK-293 cells: application to large-scale protein production. Biotechnol Prog 2005;21(1):148-53
   PubMed Web of Science ®Google Scholar
• Lee YY, Yap MGS, Hu W-S, Wong KTK. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production. Biotechnol Prog 2003;19(2):501-9
   PubMed Web of Science ®Google Scholar
• Powell T, Twist VW. A rapid technique for the isolation and purification of adult cardiac muscle cells having respiratory control and a tolerance to calcium. Biochem Biophys Res Commun 1976;72(1):327-33
   PubMed Web of Science ®Google Scholar
• Carlsson L. In vitro and in vivo models for testing arrhythmogenesis in drugs. J Intern Med 2006;259(1):70-80
   PubMed Web of Science ®Google Scholar
• Drici MD, Wang WX, Liu XK, Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. J Clin Psychopharmacol 1998;18(6):477-81
   PubMed Web of Science ®Google Scholar
• Bugaisky LB, Zak R. Differentiation of adult rat cardiac myocytes in cell culture. Circ Res 1989;64(3):493-500
   PubMed Web of Science ®Google Scholar
• Mitcheson JS, Hancox JC, Levi AJ. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res 1998;39(2):280-300
   PubMed Web of Science ®Google Scholar
• Viero C, Kraushaar U, Ruppenthal S, A primary culture system for sustained expression of a calcium sensor in preserved adult rat ventricular myocytes. Cell Calcium 2008;43(1):59-71
   PubMed Web of Science ®Google Scholar
• Volz A, Piper HM, Siegmund B, Schwartz P. Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. J Mol Cell Cardiol 1991;23(2):161-73
   PubMed Web of Science ®Google Scholar
• Meiry G, Reisner Y, Feld Y, Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes. J Cardiovasc Electrophysiol 2001;12(11):1269-77
   PubMed Web of Science ®Google Scholar
• Tung L, Zhang Y. Optical imaging of arrhythmias in tissue culture. J Electrocardiol 2006;39(4 Suppl):S2-6
   PubMed Web of Science ®Google Scholar
• Metzger JM, Lin WI, Samuelson LC. Vital staining of cardiac myocytes during embryonic stem cell cardiogenesis in vitro. Circ Res 1996;78(4):547-52
   PubMed Web of Science ®Google Scholar
• Sachinidis A, Kolossov E, Fleischmann BK, Hescheler J. Generation of cardiomyocytes from embryonic stem cells experimental studies. Herz 2002;27(7):589-97
   PubMed Web of Science ®Google Scholar
• Yuasa S, Fukuda K. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era. Expert Rev Cardiovasc Ther 2008;6(6):803-10
   PubMedGoogle Scholar
• Zhang J, Wilson GF, Soerens AG, Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104(4):e30-41-e30-41
   Web of Science ®Google Scholar
• Vidarsson H, Hyllner J, Sartipy P. Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications. Stem Cell Rev 2010;6(1):108-20
   PubMed Web of Science ®Google Scholar
• Braam SR, Tertoolen L, van de Stolpe A, Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 2010;4(2):107-16
   PubMed Web of Science ®Google Scholar
• Caspi O, Itzhaki I, Kehat I, In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev 2009;18(1):161-72
   PubMed Web of Science ®Google Scholar
• Langendorff O. Untersuchungen am uberlebenden Saugethierherzen. Pflugers Arch 1895;61(6):291-332
   Google Scholar
• Broadley KJ. The Langendorff heart preparation–Reappraisal of its role as a research and teaching model for coronary vasoactive drugs. J Pharmacol Methods 1979;2(2):143-56
   Google Scholar
• Redfern WS, Carlsson L, Davis AS, Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res 2003;58(1):32-45
   PubMed Web of Science ®Google Scholar
• Dennis A, Wang L, Wan X, Ficker E. hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem Soc Trans 2007;35:1060-3
   PubMed Web of Science ®Google Scholar
• Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 1996;94(11):2968-74
   PubMed Web of Science ®Google Scholar
• Chartrand E, Arnold AA, Gravel A, Potential role of the membrane in hERG channel functioning and drug-induced long QT syndrome. Biochim Biophys Acta 2010;1798(9):1651-62
   PubMed Web of Science ®Google Scholar
• Wynia-Smith SL, Gillian-Daniel AL, Satyshur KA, Robertson GA. hERG gating microdomains defined by S6 mutagenesis and molecular modeling. J Gen Physiol 2008;132(5):507-20
   PubMed Web of Science ®Google Scholar
• Barth AS, Tomaselli GF. Cardiac metabolism and arrhythmias. Circ Arrhythm Electrophysiol 2009;2(3):327-35
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Warner B. Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends. J Pharmacol Toxicol Methods 2010;53(2):87-105
   Google Scholar
• Hayes E, Pugsley MK, Penz WP, Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates. J Pharmacol Toxicol Methods 1994;32(4):201-7
   PubMed Web of Science ®Google Scholar
• Podrid PJ, Kowey PR. Cardiac arrhythmia: mechanisms, diagnosis, and management: Lippincott Williams & Wilkins; 2001
   Google Scholar
• Hondeghem LM, Carlsson L, Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 2001;103(15):2004-13
   PubMed Web of Science ®Google Scholar
• Oosterhoff P, Oros A, Vos MA. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs. Anadolu Kardiyol Derg 2007;7(Suppl 1):73-8
   PubMedGoogle Scholar
• Batey AJ, Doe CP. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs. J Pharmacol Toxicol Methods 2002;48(1):11-9
   PubMed Web of Science ®Google Scholar
• Thomsen MB, Oros A, Schoenmakers M, Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Cardiovasc Res 2007;73(3):521-30
   PubMed Web of Science ®Google Scholar
• Burashnikov A, Shimizu W, Antzelevitch C. Fever accentuates transmural dispersion of repolarization and facilitates development of early afterdepolarizations and torsade de pointes under long-QT Conditions. Circ Arrhythmia Electrophysiol 2008;1(3):202-8
   PubMed Web of Science ®Google Scholar
• Song Y, Belardinelli L. ATP promotes development of afterdepolarizations and triggered activity in cardiac myocytes. Am J Physiol 1994;267(5 Pt 2): H2005-11-H-11
   Web of Science ®Google Scholar
• Yan G-X, Antzelevitch C. Cellular basis for the electrocardiographic J Wave Circ 1996;93(2):372-9
   Google Scholar
• Bowlby MR, Peri R, Zhang H, Dunlop J. hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk. Curr Drug Metab 2008;9(9):965-70
   PubMed Web of Science ®Google Scholar
• Roden DM. Cellular basis of drug-induced torsades de pointes. Br J Pharmacol 2008;154(7):1502-7
   PubMed Web of Science ®Google Scholar
• Gongadze N, Kezeli T, Antelava N. Prolong QT interval and “torsades de pointes” associated with different group of drugs. Georgian Med News 2007;(153):45-9
   PubMedGoogle Scholar
• Valentin J-P, Hoffmann P, De Clerck F, Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. J Pharmacol Toxicol Methods 2004;49(3):171-81
   PubMedGoogle Scholar
• Burnashev NA, Edwards FA, Verkhratskii AN. The use of thin slices of myocardium for recording the currents across single ion channels. Fiziol Zh 1991;37(2):119-22
   PubMedGoogle Scholar
• de Boer TP, Camelliti P, Ravens U, Kohl P. Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future Cardiol 2009;5(5):425-30
   PubMedGoogle Scholar
• Yasuhara S, Takaki M, Kikuta A, Myocardial VO2 of mechanically unloaded contraction of rat ventricular slices measured by a new approach. Am J Physiol 1996;270(3 Pt 2):H1063-H70-H-H70
   Web of Science ®Google Scholar
• Han J, Kim N, Joo H, Kim E. Ketamine abolishes ischemic preconditioning through inhibition of KATP channels in rabbit hearts. Am J Physiol Heart Circ Physiol 2002;283(1):H13-21-H13-21
   Web of Science ®Google Scholar
• Pillekamp F, Halbach M, Reppel M, Neonatal murine heart slices. A robust model to study ventricular isometric contractions. Cell Physiol Biochem 2007;20(6):837-46
   PubMed Web of Science ®Google Scholar
• Hirota H. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 1999;97(2):189-98
   PubMed Web of Science ®Google Scholar
• Witt CC, Gerull B, Davies MJ, Hypercontractile properties of cardiac muscle fibers in a knock-in mouse model of cardiac myosin-binding protein-C. J Biol Chem 2001;276(7):5353-9
   PubMed Web of Science ®Google Scholar
• Du C-K, Morimoto S, Nishii K, Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 2007;101(2):185-94
   PubMed Web of Science ®Google Scholar
• Stuerz K, Guenther E, Reppel M, Organotypic ventricular heart slices of guinea pig and pig to test for drug side effects. Conference Proceedings of the 7th International Meeting on Substrate-Integrated Microelectrode Arrays; 2009: BIOPRO Baden-Wurttemberg GmbH, Stuttgart, 2010; 2009
   Google Scholar
• Habeler W, Pouillot S, Plancheron A, An in vitro beating heart model for long-term assessment of experimental therapeutics. Cardiovasc Res 2009;81(2):253-9
   PubMed Web of Science ®Google Scholar
• Wenzel J, Brandenburger M, Bogdan R, Funktionelle humane adulte ventrikulare Herzschnitte – Entwicklung eines neuen Modellsystems. Clin Res Cardiol 2009;98(Suppl 2):P87
   Google Scholar
• Adhyapak SM, Parachuri VR. Architecture of the left ventricle: insights for optimal surgical ventricular restoration. Heart Fail Rev 2010;15(1):73-83
   PubMed Web of Science ®Google Scholar
• Sicouri S, Glass A, Ferreiro M, Antzelevitch C. Transseptal dispersion of repolarization and its role in the development of Torsade de Pointes arrhythmias. J Cardiovasc Electrophysiol 2010;21(4):441-7
   PubMed Web of Science ®Google Scholar
• Habeler W, Peschanski M, Monville C. Organotypic heart slices for cell transplantation and physiological studies. Organogenesis 2009;5(2):62-6
   PubMedGoogle Scholar
• Xu B, Jacquir S, Binczak S, MEA-aided investigtion of cardiac arrhythmia induced by electrial stimulation. In: Stett A, editor, 7th edition. Int Meeting on Substrate-Integrated Microelectrode Arrays: BIOPRO edition; 2010
   Google Scholar
• Davidenko JM, Pertsov AV, Salomonsz R, Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 1992;355(6358):349-51
   PubMed Web of Science ®Google Scholar
• Antzelevitch C. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace 2007;9(Suppl 4):iv4-15
   PubMedGoogle Scholar
• Halbach M, Pillekamp F, Brockmeier K, Ventricular slices of adult mouse hearts–a new multicellular in vitro model for electrophysiological studies. Cell Physiol Biochem 2006;18(1-3):1-8
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonisation The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; 2005
   Google Scholar
• Bussek A, Wettwer E, Christ T, Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem 2009;24(5-6):527-36
   PubMed Web of Science ®Google Scholar
• Terstappen GC. Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. Assay Drug Dev Technol 2004;2(5):553-9
   PubMed Web of Science ®Google Scholar
• Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995;269(5220):92-5
   PubMed Web of Science ®Google Scholar
• Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995;81(2):299-307
   PubMed Web of Science ®Google Scholar
• Comley J. Automated patch clamping, setting a new standard for early hERG. Drug Discov World 2005;6:62-79
   Google Scholar
• Lawrence CL, Pollard CE, Hammond TG, Valentin JP. Nonclinical proarrhythmia models: predicting Torsades de Pointes. J Pharmacol Toxicol Methods 2005;52(1):46-59
   PubMedGoogle Scholar
• Shiotani M, Harada T, Abe J, Practical application of guinea pig telemetry system for QT evaluation. J Toxicol Sci 2005;30(3):239-47
   PubMedGoogle Scholar
• Lopez-Santiago LF, Meadows LS, Ernst SJ, Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J Mol Cell Cardiol 2007;43(5):636-47
   PubMed Web of Science ®Google Scholar
• van Ginneken AC, Fijnvandraat AC. Electrophysiological properties of embryonic stem cells during differentiation into cardiomyocyte-like cell types. Methods Mol Biol 2007;403:211-17
   PubMedGoogle Scholar
• Kuzmenkin A, Liang H, Xu G, Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 2009;23(12):4168-80
   PubMed Web of Science ®Google Scholar
• Pillekamp F, Reppel M, Brockmeier K, Hescheler J. Impulse propagation in late-stage embryonic and neonatal murine ventricular slices. J Electrocardiol 2006;39(4):425 e1-4
   PubMedGoogle Scholar
• Ghais NS, Zhang Y, Grace AA, Huang CL. Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts. Exp Physiol 2009;94(2):240-54
   PubMed Web of Science ®Google Scholar
• Smyrnias I, Mair W, Harzheim D, Comparison of the T-tubule system in adult rat ventricular and atrial myocytes, and its role in excitation-contraction coupling and inotropic stimulation. Cell Calcium 2010;47(3):210-23
   PubMed Web of Science ®Google Scholar
• Webb JL, Saunders PR, Thienes CH. The metabolism of the heart in relation to drug action; the action of metabolic inhibitors on rat heart slice respiration. Arch Biochem 1949;22(3):458-66
   PubMedGoogle Scholar
• Farkas A, Curtis MJ. Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing? J Cardiovasc Pharmacol 2003;42(5):612-21
   PubMed Web of Science ®Google Scholar
• Daleau P, Turgeon J. Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes. Circ Res 1994;74(6):1114-20
   PubMed Web of Science ®Google Scholar
• Watson-Wright WM, Armour JA, Johnstone DE, Wilkinson M. Myocardial slice: a physiological approach to beta-adrenergic ([3H] CGP-12177) receptor binding in hamster and guinea pig heart. J Pharmacol Methods 1989;22(1):37-47
   PubMedGoogle Scholar
• Padrini R, Speranza G, Nollo G, Adaptation of the QT interval to heart rate changes in isolated perfused guinea pig heart: influence of amiodarone and D-sotalol. Pharmacol Res 1997;35(5):409-16
   PubMed Web of Science ®Google Scholar
• Diness TG, Yeh YH, Qi XY, Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc Res 2008;79(1):61-9
   PubMed Web of Science ®Google Scholar
• Han X, Ferrier GR. Transient inward current is conducted through two types of channels in cardiac Purkinje fibres. J Mol Cell Cardiol 1996;28(10):2069-84
   PubMed Web of Science ®Google Scholar
• Tice BM, Rodriguez B, Eason J, Trayanova N. Mechanistic investigation into the arrhythmogenic role of transmural heterogeneities in regional ischaemia phase 1A. Europace 2007;9(Suppl 6):vi46-58
   PubMedGoogle Scholar
• Cheng HC, Incardona J. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts. J Pharmacol Toxicol Methods 2009;60(2):174-84
   PubMedGoogle Scholar
• Vandermolen DT, Muntz KH, Buja LM. Quantification of beta-adrenergic receptors in canine cardiac myocytes using autoradiography and an internal standard. Lab Invest 1986;54(3):353-9
   PubMed Web of Science ®Google Scholar
• Giles RW, Eikens E, Paoloni HJ, Effects of catecholamines on the coronary circulation in the Langendorff-type transplanted dog heart. Cardiovasc Res 1975;9(6):779-87
   PubMed Web of Science ®Google Scholar
• Harding SE, O'Gara P, Jones SM, Species dependence of contraction velocity in single isolated cardiac myocytes. Cardioscience 1990;1(1):49-53
   PubMedGoogle Scholar
• Carmeliet E. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart. Eur J Pharmacol 1980;61(3):247-62
   PubMed Web of Science ®Google Scholar
• Schwanke K, Wunderlich S, Reppel M, Generation and characterization of functional cardiomyocytes from rhesus monkey embryonic stem cells. Stem Cells 2006;24(6):1423-32
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131(5):861-72
   PubMed Web of Science ®Google Scholar
• Nanthakumar K, Jalife J, Masse S, Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans. Am J Physiol Heart Circ Physiol 2007;293(1):H875-80
   PubMed Web of Science ®Google Scholar
• Webster R, Leishman D, Walker D. Towards a drug concentration effect relationship for QT prolongation and torsades de pointes. Curr Opin Drug Discov Devel 2002;5(1):116-26
   PubMed Web of Science ®Google Scholar
• Meyer T, Sartipy P, Blind F, New cell models and assays in cardiac safety profiling. Expert Opin Drug Metab Toxicol 2007;3(4):507-17
   PubMed Web of Science ®Google Scholar